Researchers have developed an AI–based method that surpasses conventional approaches to analyzing structural changes in the retina related to ABCA4-associated retinopathy.
Put your patients on the path towardhelping to manage their vision
© 2022, Regeneron Pharmaceuticals, Inc. All rights reserved.
Public & Patients
Museum of the Eye